ARE stock · MXCT stock

ARE vs MXCT · P/E 100, $13.19B cap vs rev $38.6M

Alexandria Real Estate Equities Inc (ARE) versus MaxCyte Inc (MXCT) — a side-by-side from cached financials, not a winner call.

Alexandria Real Estate Equities Inc (ARE) is a reit - office company listed on US.

MaxCyte Inc (MXCT) is a medical devices company listed on NASDAQ.

ARE does not have a complete income-statement cache yet.

Latest reported MXCT revenue for 2024-12-31 was $38.6M. Net income was -$41.1M. Revenue was down 6.4% from 2023-12-31 to 2024-12-31. MXCT currently screens at market cap $124.3M.

ARE currently screens at market cap $13.19B and trailing P/E 100.4. MXCT currently screens at market cap $124.3M.

Not investment advice. Open the ARE and MXCT stock pages for the full models.

Not investment advice.

Popular Stock Comparisons